You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tace

Showing 26 - 50 of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Shanghai (Lenvatinib, TACE)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Department of Interventional Radiology, Zhongshan Hospital, Fuda
Sep 23, 2021

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE
  • +8 more
  • Quanzhou, Fujian, China
  • +3 more
Jan 29, 2023

Hepatocellular Carcinoma Trial in Germany, Spain (Atezolizumab, Bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Aachen, Germany
  • +8 more
Dec 20, 2021

Hepatocellular Carcinoma Trial in Shanghai (Lenvatinib 4 MG Oral Capsule [Lenvima], Toripalimab, TACE)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • Lenvatinib 4 MG Oral Capsule [Lenvima]
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Zhongshan Hospital
Sep 23, 2021

Hepatocellular Carcinoma, Adjuvant Therapy Trial in Hangzhou (Tislelizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Adjuvant Therapy
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jan 4, 2022

BCLC Stage C Hepatocellular Carcinoma Trial in Hangzhou (TACE, Tilelizumab, Sorafenib)

Not yet recruiting
  • BCLC Stage C Hepatocellular Carcinoma
  • TACE
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Aug 10, 2021

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Tislelizumab, TACE)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 13, 2021

Hepatocellular Carcinoma Trial in Shanghai (Sintilimab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 13, 2021

Hepatocellular Carcinoma, Lenvatinib Trial (Lenvatinib, TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib
  • (no location specified)
Jun 2, 2021

Hepatic Carcinoma Trial in Shanghai (Sintilimab, Microwave Ablation, TACE)

Recruiting
  • Hepatic Carcinoma
  • Shanghai, Shanghai, China
    Department of Interventional Radiology, Zhongshan Hospital, Fuda
Sep 23, 2021

HCC Trial in Hong Kong (procedure, radiation, drug)

Recruiting
  • HCC
  • TACE
  • +3 more
  • Hong Kong, Hong Kong
  • +1 more
Jul 23, 2021

Hepatocellular Carcinoma Trial in Hangzhou (Sintilimab Injection, TACE, Radiotherapy)

Terminated
  • Hepatocellular Carcinoma
  • Sintilimab Injection
  • +2 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Dec 21, 2021

TACE Combined With Lenvatinib for Unresectable Hepatocellular

Unknown status
  • Carcinoma, Hepatocellular
  • (no location specified)
Sep 22, 2020

Hepatocellular Carcinoma Trial (Sintilimab, TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Apr 11, 2021

Cancer, Hepatocellular Trial in Worldwide (nivolumab, ipilimumab, TACE)

Active, not recruiting
  • Cancer, Hepatocellular
  • Coronado, California
  • +117 more
Oct 11, 2022

Hepatocellular Carcinoma Trial in Shanghai (Anti-angiogenic Targeted Drugs, Ginsenoside Rg3, TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Anti-angiogenic Targeted Drugs
  • +2 more
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Aug 19, 2020

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Hepatocellular Carcinoma Trial in Taoyuan (sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Feb 4, 2020

Hepatocellular Carcinoma Trial in Nanning (procedure, drug, other)

Recruiting
  • Hepatocellular Carcinoma
  • TACE
  • +3 more
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 7, 2020

Carcinoma, Hepatocellular Trial in Hangzhou (TACE, Anlotinib Hydrochloride)

Unknown status
  • Carcinoma, Hepatocellular
  • TACE
  • Anlotinib Hydrochloride
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 22, 2019

Heptocellular Cancer, Biliary Tract Tumors, Liver Cancer Trial run by the NCI (Tremelimumab, RFA, TACE)

Completed
Has Results
  • Heptocellular Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 21, 2019

Hepatocellular Carcinoma Trial in Xi'an (Sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • Xi'an, Shaanxi, China
    Xijing Hospital of digestive disease, Fourth Military Medical Un
Jul 31, 2019

Hepatocellular Carcinoma Trial in Xi'an (Sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • Xi'an, Shaanxi, China
    Xijing Hospital of Digestive Disease
Jul 31, 2019

Advanced Hepatocellular Carcinoma Trial in Guangzhou (TACE, Lenvatinib)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Aug 19, 2019

Colorectal Adenocarcinoma Metastatic to the Liver Trial in Shanghai (TACE, chemo±target therapy)

Unknown status
  • Colorectal Adenocarcinoma Metastatic to the Liver
  • TACE
  • chemotherapy±target therapy
  • Shanghai, China
    Department of General Surgery, Zhongshan Hospital, Fudan Univers
Jun 11, 2019